Status:

TERMINATED

Daily Co-trimoxazole Prophylaxis to Prevent Malaria in Pregnancy

Lead Sponsor:

Institute of Tropical Medicine, Belgium

Collaborating Sponsors:

Tropical Diseases Research Centre, Zambia

Conditions:

Malaria in Pregnancy

Eligibility:

FEMALE

Phase:

PHASE3

Brief Summary

Malaria is a major contributor of disease burden in Sub-Saharan Africa, and pregnant women and children are the most vulnerable population. Malaria in pregnancy increases the risks of abortion, premat...

Detailed Description

Malaria is a major contributor of disease burden in Sub-Saharan Africa, with pregnant women and children being the most vulnerable population. P. falciparum infection in pregnancy leads to parasite se...

Eligibility Criteria

Inclusion

  • Confirmed pregnancy (through palpable fundus and/ or positive pregnancy test)
  • Gestational age between 16 and 28 weeks.
  • Informed consent by patient (or parent/ guardian if patient is less than 18 years of age)
  • No symptoms consistent with malaria
  • Willingness to deliver at the health facility
  • Willingness to adhere to all requirements of the study (including HIV-1 testing)

Exclusion

  • History of allergy to study drugs, or previous history of allergy to sulpha drugs
  • History or presence of major illnesses likely to influence pregnancy outcome including diabetes mellitus, severe renal or heart disease, or active tuberculosis, prior to randomization;
  • Any significant illness that requires hospitalization;
  • Intent to move out of the study catchment's area before delivery or deliver at relative's home out of the catchment's area;
  • Prior enrolment in the study or concurrent enrolment in another study
  • Severe anaemia (Hb\<7 g/dl)
  • Previous history of unfavourable pregnancy outcome: pre-eclampsia, caesarean section, stillbirth.
  • Being HIV infected and already receiving CTX prophylaxis or ARV treatment

Key Trial Info

Start Date :

February 1 2009

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

September 1 2010

Estimated Enrollment :

352 Patients enrolled

Trial Details

Trial ID

NCT00711906

Start Date

February 1 2009

End Date

September 1 2010

Last Update

January 18 2016

Active Locations (2)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (2 locations)

1

Choma hospital

Choma, Zambia

2

Shampande Clinic

Shampande, Zambia